Subscribe To
Biostem technologies closes oversubscribed $2m private placement
POMPANO BEACH, Fla., Nov. 03, 2023 (GLOBE NEWSWIRE) — BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the ...
November 3, 2023, 12:30 pm
Turnstone biologics presents preclinical data highlighting potential for selected tumor-infiltrating lymphocyte (til) therapy in solid tumors at the 2023 society for immunotherapy of cancer (sitc) ann
Presentations showcase Turnstone’s novel Selected TIL programs which are designed to selectively expand the most potent tumor-reactive T cells for t...
November 3, 2023, 10:00 am
Abcellera biologics inc. (abcl) q3 2023 earnings call transcript
AbCellera biologics Inc. (NASDAQ:ABCL ) Q3 2023 Results Conference Call November 2, 2023 5:00 PM ET Com...
November 2, 2023, 9:18 pm
Adma biologics (adma) stock falls amid market uptick: what investors need to know
Adma biologics (ADMA) closed the most recent trading day at $3.45, moving -1.99% from the previous trad...
November 2, 2023, 6:47 pm
Ocugen to host conference call on thursday, november 9 at 8:30 a.m. et to discuss business updates and third quarter 2023 financial results
MALVERN, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, ...
November 2, 2023, 11:30 am
Autolus therapeutics reports third quarter 2023 financial results and business updates
Obe-cel, a potentially transformational treatment for relapsed/refractory (r/r) adult B-cell Acute Lymphoblastic Leukemia (ALL), on track for a ...
November 2, 2023, 11:11 am
Masonic cancer center, university of minnesota to present data in poster presentation human data readout for phase 1 study to evaluate hcw9218 in solid tumors at sitc 38th annual meeting
HCW9218 is the lead product candidate of HCW biologics Inc. MIRAMAR, Fla., Nov. 01, 2023 (GLOBE NEWSWIR...
November 1, 2023, 11:30 am
Mustgrow receives usda organic certification for terrasante crop fertilizer
MustGrow biologics Corp. (TSX-V:MGRO, OTCQB:MGROF) has achieved a significant milestone by obtaining or...
October 31, 2023, 8:48 am
Adma biologics (adma) ascends while market falls: some facts to note
Adma biologics (ADMA) closed at $3.31 in the latest trading session, marking a +0.91% move from the pri...
October 27, 2023, 6:48 pm
Astrazeneca said u.s. fda has accepted for review its flumist self-administered flu vaccine
AstraZeneca PLC AZN, -1.22% AZN, +1.45% said Tuesday the U.S. Food and Drug Administration has accepted its application for approval of a self-adminis...
October 24, 2023, 7:21 am
Adma biologics (adma) rises as market takes a dip: key facts
In the most recent trading session, Adma biologics (ADMA) closed at $3.44, indicating a +1.78% shift fr...
October 17, 2023, 7:33 pm
Avid bioservices completes construction of new, world-class cell and gene therapy development and manufacturing facility
Newly Launched CGMP Manufacturing Suites Undergoing Final Environmental Monitoring and Performance Qualification with Grand Opening Planned for Januar...
October 17, 2023, 12:05 pm
Adma biologics (adma) stock sinks as market gains: here's why
In the closing of the recent trading day, Adma biologics (ADMA) stood at $3.34, denoting a -0.3% change...
October 9, 2023, 7:33 pm
Defence to present three of its leading products at the upcoming festival of biologics in basel, switzerland
Vancouver, British Columbia--(Newsfile Corp. - October 6, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the ...
October 6, 2023, 6:00 pm
Thermo fisher (tmo) expands capabilities in st. louis facility
Thermo Fisher (TMO) expands manufacturing capacity at the St. Louis site for biologics treatment....
October 6, 2023, 9:01 am
Lonza group: downside scenario already priced in
Lonza's CEO departure raises questions about business continuity, but we believe the stock price already reflects the worst-case scenario. Lower CAPEX...
October 5, 2023, 4:55 am
Catalent remains overvalued
Catalent, Inc.'s revenue and scale have suffered due to the decline in vaccine deliveries, particularly in its ...
October 4, 2023, 1:08 pm
Chitogenx receives notice of allowance for key patent in the us and canada
ChitogenX Inc (CSE:CHGX, OTCQB:CHNXF) told investors it has received a notice of allowance for a key patent in the US and Canada. The company noted th...
September 28, 2023, 8:17 am
Aclaris therapeutics: the many lives of this biopharmaceutical developer
Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indications. The company's platform, KINect, helps ...
September 28, 2023, 7:18 am
Bullfrog ai founder and ceo vin singh to present company overview at biofuture 2023
GAITHERSBURG, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a te...
September 25, 2023, 12:00 pm